Increased incidence of benign breast disease in female renal transplant patients receiving cyclosporin
- 19 March 2002
- journal article
- research article
- Published by Wiley in Anz Journal of Surgery
- Vol. 72 (3), 222-225
- https://doi.org/10.1046/j.1445-2197.2002.02352.x
Abstract
Background: Unlike other cancers, breast cancer does not occur at increased frequency in renal transplant patients but fibroadenomata may be more common as a result of exposure to cyclosporin. In order to determine the incidence of benign breast disease in renal transplant patients at Monash Medical Centre, current female patients were studied. Methods: The study was divided into two parts: (i) a retrospective review of those who presented with clinically detectable breast lumps; and (ii) mammographic screening of current female transplant patients who had been transplanted for more than 1 year. Results: In the retrospective study there were 11 patients with 16 breast lumps among a total of 85 patients. All were confirmed by biopsy. The mean age at diagnosis of breast lumps was 41.5 years (range 25–70 years). The mean time to presentation was 3.5 years after transplantation. Nine out of 11 patients had benign breast disease including fibroadenoma (six patients), fibrocystic disease (two patients) and intraductal papillomatosis (one patient). Two patients had breast cancer. Five of the patients with fibroadenoma had multiple lumps and a recurrent course. All patients with fibroadenomata had received cyclosporin. In the second part, 54 patients were further screened. The mean duration of transplantation was 6.4 years (range 1.25–18.5 years). Eighty‐seven per cent of the patients had received cyclosporin, and 80% had a negative (normal) study. Seven of 54 had abnormalities including cysts and calcification, of whom two patients had fibroadenomata. Four patients had ‘dense mammograms’, all of whom received cyclosporin as a part of their immunosuppression. No breast cancer was detected during the study. Conclusion: The incidence of benign breast disease in the female transplant patients studied was far greater then the general population. The increase in fibroadenomata, in particular, may relate to the use of cyclosporin.Keywords
This publication has 24 references indexed in Scilit:
- Mammographic densities and the prevalence and incidence of histological types of benign breast diseaseEuropean Journal of Cancer Prevention, 2000
- Some aspects of the history of early dialysis registriesNephrology, 1998
- Cyclosporin‐A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitroJournal of Oral Pathology & Medicine, 1992
- Diagnosing breast carcinoma in young women.BMJ, 1991
- Fibroadenoma of the breast: A follow-up of conservative managementBritish Journal of Surgery, 1989
- Familial bilateral multiple fibroadenomas of the breastPublished by Oxford University Press (OUP) ,1985
- Gingival hyperplasia induced by cyclosporin-ABritish Dental Journal, 1984
- Rapid elevation of rat serum prolactin concentration by cyclosporine, a novel immunosuppressive drugBiochemical and Biophysical Research Communications, 1984
- The comparative epidemiology of benign breast lumps and breast cancer in Western AustraliaInternational Journal of Cancer, 1982
- TWO CASES OF BENIGN LUMPS AFTER TREATMENT WITH CYCLOSPORIN AThe Lancet, 1980